TOZADENANT

Pharmaceutical products and preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; medical and veterinary products and preparations, namely, disposable and non-disposable injectors, sprays, inhalers and syringe pens, all sold filled with pharmaceutical preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; diagnostic products and preparations for medical and veterinary purposes, namely, antibodies for disease testing, diagnostic kits for medical and veterinary purposes consisting of antibodies for disease testing; biological products and preparations for medical and veterinary purposes, namely, antibodies, polynucleic acid molecules, polypeptides and proteins